Actually my comment at the start of this page referred to the graph on page 5 of the Clinical Trial update on 18th Jan. Sorry I should have been more specific.
Between week 8 and 12 of the in three groups there seemed to be a regress in average cover in 2 and no improvement in 1. It can most probably be explained, but it hasn't and to the mug punter on the surface it can look quite negative. Is it swayed by the control group? The Vitrocard is the "standard to compare" and is starting to lag a bit.
So, any thoughts on that?
Actually my comment at the start of this page referred to the...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
